Navigation Links
Synthetic Biologics to Participate in Fireside Chat at RBC Capital Markets' Global Healthcare Conference
Date:2/16/2016

ROCKVILLE, Md., Feb. 16, 2016 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a clinical stage company focused on developing therapeutics to protect the gut microbiome, announced today that Jeffrey Riley, President & Chief Executive Officer, is scheduled to participate in an analyst-led fireside chat with the Company's covering analyst, Adnan Butt, at the 2016 RBC Capital Markets Global Healthcare Conference on Tuesday, February 23, at 4:35 p.m. (ET) in the Holmes II room at the New York Palace Hotel in New York.

A live webcast of Synthetic Biologics' fireside chat may be accessed by logging onto the internet at https://www.veracast.com/webcasts/rbc/healthcare2016/17116241334.cfm. After the discussion, a replay will be archived and accessible for 90 days at the same website.

About Synthetic Biologics, Inc.

Synthetic Biologics, Inc. (NYSE MKT: SYN) is a clinical stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases. The Company's lead candidates in Phase 2 development include: (1) SYN-004 which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection and antibiotic-associated diarrhea (AAD), and (2) SYN-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat an underlying cause of irritable bowel syndrome with constipation (IBS-C). In collaboration with Intrexon Corporation (NYSE: XON), the Company is developing a preclinical stage monoclonal antibody for the prevention and treatment of Pertussis, and discovery stage biotherapeutics for the treatment of phenylketonuria (PKU). For more information, please visit Synthetic Biologics' website at www.syntheticbiologics.com.                                                  

Logo - http://photos.prnewswire.com/prnh/20160105/319502LOGO

 


'/>"/>
SOURCE Synthetic Biologics, Inc.
Copyright©2016 PR Newswire.
All rights reserved


Related biology technology :

1. Express Genes by Eurofins MWG Operon Offers 4 Day Delivery of Synthetic Genes
2. Synthetic Biologics Reiterates that the Infectious Disease Collaboration with Intrexon Remains in Effect
3. Intrexon Corporation Raises $150 Million for Synthetic Biology Initiatives
4. Intrexon Organizes Around New Synthetic Biology Markets
5. Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference
6. New England Biolabs supports iGEM synthetic biology competition
7. Synthetic Biologics to Present at OneMedForum New York 2013
8. Synthetic DNA Deemed Patentable by US Supreme Court, Gene Synthesis and Codon Optimization Provide Potential Pathway to Patentability
9. Synthetic Biologics Initiates Manufacturing Process for C. difficile Infectious Disease Program
10. Synthetic Biologics to Report Second Quarter 2013 Financial Results
11. Synthetic Biologics Reports Second Quarter 2013 Financial Results and Operational Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/15/2018)... ... November 14, 2018 , ... Hüpnos announces the ... the public. It is estimated that 90 million Americans suffer from ... partner. The resulting daytime fatigue causes extreme difficulty with concentration, focus and memory. ...
(Date:11/13/2018)... ... November 12, 2018 , ... ... in Alpharetta and Sandy Springs, now welcomes new patients for MTM® Clear Aligners. ... comfortable alternative to traditional braces in the Sandy Springs and Alpharetta areas. Constantly ...
(Date:11/13/2018)... ... November 13, 2018 , ... Sharon ... Life Science® in Grants Pass, Oregon believes in the power of talk radio ... Water Life Science® sponsors the Power of Water® on talk radio every week ...
(Date:11/9/2018)... ... November 08, 2018 , ... ... adopted a machine-learning powered approach to increasing recovery rates by creating a comprehensive ... Intelligent Collections (AIC) product developed by NLP Logix, a Jacksonville, Florida-based AI solutions ...
Breaking Biology Technology:
(Date:11/27/2018)... ... November 27, 2018 , ... Veni Vici, or Anthony, is a competitive Hunter-Jumper owned by ... At the time, he was fourteen years old and Lisa was told he would ... to be a trail horse. Devasted, Lisa sought the expert opinion of veterinarian and ...
(Date:11/20/2018)... ... , ... Cloudponics , maker of the GroBox , the intelligent, ... $420 for its industry-leading product during the holiday season. , Customers can save ... and payment options available on the Cloudponics website . , “We aim, ...
(Date:11/20/2018)... Calif. (PRWEB) , ... November 19, 2018 , ... ... Emsculpt in the Bay Area -- the first and only non-invasive buttock ... contractions, Emsculpt is FDA cleared to strengthen, tone and firm the buttocks to ...
Breaking Biology News(10 mins):